Bronchiectasis Adult Clinical Trials

14 recruitingLast updated: May 5, 2026

There are 14 actively recruiting bronchiectasis adult clinical trials across 8 countries. Studies span Not Applicable, Phase 3, Phase 4. Top locations include Shanghai, Shanghai Municipality, China, Jinan, Shangdong, China, Jiaxing, Zhejiang, China. Updated daily from ClinicalTrials.gov.


Bronchiectasis Adult Trials at a Glance

14 actively recruiting trials for bronchiectasis adult are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Shanghai, Jinan, and Jiaxing. Lead sponsors running bronchiectasis adult studies include Shanghai Pulmonary Hospital, Shanghai, China, Imperial College London, and IRCCS Azienda Ospedaliero-Universitaria di Bologna.

Browse bronchiectasis adult trials by phase

Treatments under study

About Bronchiectasis Adult Clinical Trials

Looking for clinical trials for Bronchiectasis Adult? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bronchiectasis Adult trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bronchiectasis Adult clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)

Bronchiectasis Adult
Synchrony-Medical, Ltd200 enrolled3 locationsNCT07135284
Recruiting
Not Applicable

Comparison Between Conventional Respiratory Physiotherapy and the Simeox Device in Patients With Bronchiectasis

Bronchiectasis Adult
IRCCS Azienda Ospedaliero-Universitaria di Bologna40 enrolled1 locationNCT06801327
Recruiting
Not Applicable

Role of BARriers in IgG-Pathogen Interactions at the Mucosal Surface in Human Airways

Bronchiectasis Adult
University Hospital, Tours30 enrolled1 locationNCT06670937
Recruiting

Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis

Bronchiectasis AdultCystic Fibrosis (CF)
Papworth Hospital NHS Foundation Trust50 enrolled1 locationNCT07289100
Recruiting

The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China1,500 enrolled9 locationsNCT06900062
Recruiting

Exploring How Viral Infections Affect People With Chronic Lung Disease

COPD, Chronic Obstructive Pulmonary DiseaseBronchiectasis with Acute ExacerbationBronchiectasis Adult+1 more
Imperial College London180 enrolled1 locationNCT06625944
Recruiting
Not Applicable

A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis

Viral InfectionBronchiectasis with Acute ExacerbationBronchiectasis Adult+2 more
Imperial College London54 enrolled1 locationNCT06931002
Recruiting

Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China364 enrolled58 locationsNCT06760273
Recruiting
Phase 4

Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China364 enrolled63 locationsNCT06093191
Recruiting

Cardiopulmonary Responses to 6-Minute Stepper Test in Bronchiectasis Versus Healthy Controls

Bronchiectasis AdultHealthy Controls Group - Age and Sex-matched
Hacettepe University60 enrolled1 locationNCT06631261
Recruiting
Phase 3

Benefits of Inhalation of Hypertonic Saline Solution Prior to Physiotherapy ELTGOL Technique in Bronchiectasis

Bronchiectasis Adult
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta57 enrolled1 locationNCT06443658
Recruiting
Not Applicable

Airway Clearance Technique of Oscillation and Lung Expansion in Bronchiectasis

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China96 enrolled3 locationsNCT06393257
Recruiting

The BRIDGE Study - Bronchiectasis Research Involving Databases, Genomics and Endotyping

Bronchiectasis Adult
University of Dundee1,000 enrolled1 locationNCT03791086
Recruiting

A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong

Bronchiectasis Adult
Chinese University of Hong Kong400 enrolled1 locationNCT04538859